In contrast to increased GC sensitivity in metabolic tissues, there is impaired GR signaling in PBMCs in T2D which is associated with hyperglycemia, hyperlipidemia, and increased inflammation. The gene discussed is NR3C1; the disease is type 2 diabetes mellitus.